2160 fundamentals
An in-depth look to MICROPORT CARDIOFLOW MEDTECH CORP operating, investing, and financing activities
2160 free cash flow for H2 23 is -89 M HKD. For 2023, 2160 free cash flow was -249.77 M HKD and operating cash flow was -218.91 M HKD.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: HKD
TTM